This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. MRNA slipped 1.79% to $158.02 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 4.06% to 12,032.42 and the Dow Jones Industrial Average DJIA rising 1.37% to 32,197.59. This was the stock's second consecutive day of losses. Moderna Inc. closed $339.47 short of its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. ABBV rose 0.19% to $151.15, Amgen Inc. AMGN rose 0.23% to $251.72, and AstraZeneca PLC ADR AZN rose 1.15% to $67.49. Trading volume (4.2 M) remained 1.0 million below its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2022.
(END) Dow Jones Newswires
July 27, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.